Protein Traffic Disorders: an Effective High-Throughput Fluorescence Microscopy Pipeline for Drug Discovery-Reference-Cited by-同舟云学术

Protein Traffic Disorders: an Effective High-Throughput Fluorescence Microscopy Pipeline for Drug Discovery

Published:2015-03-12 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Botelho Hugo M.,Uliyakina Inna,Awatade Nikhil T.,Proença Maria C.,Tischer Christian,Sirianant Lalida,Kunzelmann Karl,Pepperkok Rainer,Amaral Margarida D.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep09038.pdf

Reference47 articles.

1. Fagerberg, L., Jonasson, K., von Heijne, G., Uhlen, M. & Berglund, L. Prediction of the human membrane proteome. Proteomics 10, 1141–1149 (2010).

2. Aridor, M. Visiting the ER: the endoplasmic reticulum as a target for therapeutics in traffic related diseases. Adv. Drug Deliv. Rev. 59, 759–781 (2007).

3. De Matteis, M. A. & Luini, A. Mendelian disorders of membrane trafficking. N. Engl. J. Med. 365, 927–938 (2011).

4. Hutt, D. M., Powers, E. T. & Balch, W. E. The proteostasis boundary in misfolding diseases of membrane traffic. FEBS Lett. 583, 2639–2646 (2009).

5. Denning, G. M., Ostedgaard, L. S. & Welsh, M. J. Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia. J. Cell Biol. 118, 551–559 (1992).

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microscale thermophoresis (MST) and spectral shift (SpS) in drug discovery;TrAC Trends in Analytical Chemistry;2024-07

2. PTI-801 (posenacaftor) shares a common mechanism with VX-445 (elexacaftor) to rescue p.Phe508del-CFTR;European Journal of Pharmacology;2024-03

3. Synthesis and Evaluation of Ivacaftor Derivatives with Reduced Lipophilicity;ACS Omega;2023-11-25

4. YES1 Kinase Mediates the Membrane Removal of Rescued F508del-CFTR in Airway Cells by Promoting MAPK Pathway Activation via SHC1;Biomolecules;2023-06-06

5. Development of novel therapeutics for all individuals with CF (the future goes on);Journal of Cystic Fibrosis;2023-03